Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.57
97% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.6M | $22.3M | $15.6M | $16.8M | $23.5M | $17.5M | $19.6M | $21.1M |
| Cost of revenue | $5.5M | $5.8M | $4.4M | $6.8M | $10.3M | $7.2M | $10.0M | $10.7M |
| Gross profit | $11.1M | $16.5M | $11.3M | $10.0M | $13.2M | $10.4M | $9.6M | $10.4M |
| Gross margin | 66.7% | 74.0% | 72.1% | 59.7% | 56.0% | 59.1% | 49.1% | 49.1% |
| R&D | $1.1M | $1.4M | $1.1M | $634.0K | $609.0K | $699.0K | $646.0K | $573.5K |
| Operating income | −$37.0K | $5.0M | $1.6M | −$719.0K | $529.0K | −$2.0M | −$3.2M | −$1.0M |
| EBITDA | $1.1M | $6.7M | $2.3M | $606.0K | $2.0M | −$450.0K | −$1.3M | $478.6K |
| Net income | $2.4M | $1.9M | $37.0K | −$1.1M | $862.0K | −$2.0M | −$2.8M | −$91.9K |
| Net margin | 14.4% | 8.3% | 0.2% | -6.6% | 3.7% | -11.3% | -14.0% | -0.4% |
| EPS (diluted) | 0.12 | 0.08 | 0.00 | -0.05 | 0.04 | -0.10 | -0.14 | -0.00 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds CRRTF.
No tracked institution reports a position in CRRTF as of their last filing.
No one on the platform has traded CRRTF yet.
| $5M |
| — |
| CNFHFCanaFarma Hemp Products Corp. | $0.00 | +0.00% | $19561 | — |
| CVSICV Sciences, Inc. | $0.02 | +0.00% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.6× sales vs its 0.4× historical median P/S.
Fair value ≈ $0.37 · price $0.56 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.